Drug disposition in the late preterm ("near-term") newborn.

Late preterm newborns often require treatment with potent drugs. Drug disposition is inadequately studied in this population, but when studied it is usually immature compared with that of term newborns. This immaturity reflects biologic immaturity and can be analyzed systematically according to the principal steps in pharmacokinetics: absorption, distribution, metabolism, and elimination. When studied developmentally, drug disposition often does not mature linearly with age, nor necessarily in predictable or generalizable patterns. Instead, more detailed study of specific pathways of drug disposition is needed in the late preterm newborn to support safe and effective drug therapy.

[1]  R. Ward,et al.  Chapter 20 – Basic Pharmacokinetic Principles , 2003 .

[2]  W. Fox,et al.  Fetal and Neonatal Physiology , 2003 .

[3]  D. Moore,et al.  Induction of bilirubin clearance by the constitutive androstane receptor (CAR) , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  V. Fellman,et al.  Gestational age and birth weight effects on plasma clearance of fentanyl in newborn infants. , 2000, The Journal of pediatrics.

[5]  P. Tulkens,et al.  Aminoglycosides: Activity and Resistance , 1999, Antimicrobial Agents and Chemotherapy.

[6]  R. V. van Lingen,et al.  Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates , 1999, Archives of disease in childhood. Fetal and neonatal edition.

[7]  T. Cresteil,et al.  Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. , 1997, European journal of biochemistry.

[8]  J. S. Leeder,et al.  Pharmacogenetics in pediatrics. Implications for practice. , 1997, Pediatric clinics of North America.

[9]  G. Mccracken.  Arninoglycoside toxicity in infants and children , 1986 .

[10]  G. Koren,et al.  A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn , 1985, Clinical pharmacology and therapeutics.

[11]  G. Heimann.  Renal toxicity of aminoglycosides in the neonatal period. , 1983, Pediatric pharmacology.

[12]  A. Aperia,et al.  POSTNATAL DEVELOPMENT OF RENAL FUNCTION IN PRE‐TERM AND FULL‐TERM INFANTS , 1981, Acta paediatrica Scandinavica.

[13]  G. Avery.  Neonatology: Pathophysiology and management of the newborn , 1981 .

[14]  B. Arant,et al.  Pathophysiologic Evidence of Gentamicin Nephrotoxicity in Neonatal Puppies , 1980, Pediatric Research.

[15]  F. Silverblatt,et al.  Autoradiography of gentamicin uptake by the rat proximal tubule cell. , 1979, Kidney international.

[16]  A H Neims,et al.  Pharmacokinetic aspects of theophylline in premature newborns. , 1976, The New England journal of medicine.

[17]  R. J. Roberts,et al.  Acetaminophen elimination kinetics in neonates, children, and adults , 1976, Clinical pharmacology and therapeutics.

[18]  B. Friis‐Hansen.  Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth. , 1971, Pediatrics.

[19]  A. Conney,et al.  The Newborn: REDUCTION IN CONCENTRATION OF TOTAL SERUM-BILIRUBIN IN OFFSPRING OF WOMEN TREATED WITH PHENOBARBITONE DURING PREGNANCY , 1969 .

[20]  B. Friis‐Hansen.  Body water compartments in children: changes during growth and related changes in body composition. , 1961, Pediatrics.